MDS-话题@MedSci - 梅斯（MedSci）

#MDS#

59篇内容 | 3106人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1842826, encodeId=7ce918428269c, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, objectType=article, longId=207335, objectId=402b20e335fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=402b20e335fd, replyNumber=0, likeNumber=102, createdTime=2021-10-19, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402b20e335fd, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=402b20e335fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842825, encodeId=bf41184282529, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, objectType=article, longId=206018, objectId=3311206018ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3311206018ec, replyNumber=0, likeNumber=122, createdTime=2021-02-03, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3311206018ec, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3311206018ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842824, encodeId=b984184282497, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：短端粒长度可预测MDS患者干细胞移植后的无复发死亡率, objectType=article, longId=205190, objectId=4cae20519053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cae20519053, replyNumber=0, likeNumber=111, createdTime=2021-02-10, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cae20519053, moduleTitle=Blood：短端粒长度可预测MDS患者干细胞移植后的无复发死亡率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4cae20519053)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842821, encodeId=5abb184282132, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=CAR-T细胞疗法MB-102治疗BPDCN、AML、hrMDS：即将开展多中心I/II期临床试验, objectType=article, longId=201543, objectId=a72820154315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a72820154315, replyNumber=0, likeNumber=91, createdTime=2021-09-04, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a72820154315, moduleTitle=CAR-T细胞疗法MB-102治疗BPDCN、AML、hrMDS：即将开展多中心I/II期临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a72820154315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842818, encodeId=5c5c184281864, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例, objectType=article, longId=197237, objectId=b6f419e237c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6f419e237c9, replyNumber=0, likeNumber=139, createdTime=2020-10-16, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6f419e237c9, moduleTitle=地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b6f419e237c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842812, encodeId=57251842812ef, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=阿扎胞苷为MDS去甲基化治疗**, objectType=article, longId=183952, objectId=a66c18395220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a66c18395220, replyNumber=0, likeNumber=154, createdTime=2020-03-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a66c18395220, moduleTitle=阿扎胞苷为MDS去甲基化治疗**, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a66c18395220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842816, encodeId=3231184281686, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, objectType=article, longId=192727, objectId=297f192e2779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=297f192e2779, replyNumber=0, likeNumber=0, createdTime=2020-12-05, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=297f192e2779, moduleTitle=Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=297f192e2779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842817, encodeId=d517184281e9b, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：MDS/MPN不同亚型的遗传异质性, objectType=article, longId=196875, objectId=78f11968e54e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f11968e54e, replyNumber=0, likeNumber=144, createdTime=2020-10-03, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f11968e54e, moduleTitle=Blood：MDS/MPN不同亚型的遗传异质性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=78f11968e54e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842815, encodeId=bef81842815aa, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：SETD2缺陷预示MDS预后不良，并加速MDS-白血病转化, objectType=article, longId=190745, objectId=d5f7190e452a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5f7190e452a, replyNumber=0, likeNumber=112, createdTime=2020-06-11, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5f7190e452a, moduleTitle=Blood：SETD2缺陷预示MDS预后不良，并加速MDS-白血病转化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d5f7190e452a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842813, encodeId=133418428135d, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后, objectType=article, longId=185331, objectId=f042185331ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f042185331ad, replyNumber=0, likeNumber=100, createdTime=2020-10-26, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f042185331ad, moduleTitle=Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f042185331ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842810, encodeId=d436184281093, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：MDS/AML成人患者的生殖细胞DDX41突变, objectType=article, longId=179007, objectId=c2e61e9007cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e61e9007cd, replyNumber=0, likeNumber=76, createdTime=2020-01-11, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e61e9007cd, moduleTitle=Blood：MDS/AML成人患者的生殖细胞DDX41突变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c2e61e9007cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842807, encodeId=b791184280eea, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？, objectType=article, longId=175935, objectId=6da11e593555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6da11e593555, replyNumber=0, likeNumber=86, createdTime=2020-02-03, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6da11e593555, moduleTitle=IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6da11e593555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842806, encodeId=b78c184280630, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS, objectType=article, longId=167568, objectId=817016e5685e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817016e5685e, replyNumber=0, likeNumber=110, createdTime=2020-02-24, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817016e5685e, moduleTitle=IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=817016e5685e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842814, encodeId=521318428147e, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Cell Death Dis：间充质干细胞通过扩增MDSCs促进癌细胞存活转移, objectType=article, longId=186149, objectId=be87186149d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be87186149d1, replyNumber=0, likeNumber=90, createdTime=2020-09-27, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be87186149d1, moduleTitle=Cell Death Dis：间充质干细胞通过扩增MDSCs促进癌细胞存活转移, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=be87186149d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842811, encodeId=9de9184281140, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=高危MDS的治疗策略选择及阿扎胞苷的应用地位及进展, objectType=article, longId=180796, objectId=c95b180e961d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95b180e961d, replyNumber=0, likeNumber=72, createdTime=2020-07-04, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95b180e961d, moduleTitle=高危MDS的治疗策略选择及阿扎胞苷的应用地位及进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c95b180e961d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842809, encodeId=433718428092d, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Prostate：STAT3抑制剂肉盘菌内酯能够抑制类MDSC单核细胞的产生, objectType=article, longId=177449, objectId=112c1e744960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=112c1e744960, replyNumber=0, likeNumber=63, createdTime=2019-12-12, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=112c1e744960, moduleTitle=Prostate：STAT3抑制剂肉盘菌内酯能够抑制类MDSC单核细胞的产生, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=112c1e744960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842808, encodeId=3a1f18428088f, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后, objectType=article, longId=177371, objectId=98671e7371f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98671e7371f8, replyNumber=0, likeNumber=70, createdTime=2020-05-20, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98671e7371f8, moduleTitle=Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=98671e7371f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842802, encodeId=3b951842802cd, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究, objectType=article, longId=159068, objectId=21bc15906861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21bc15906861, replyNumber=0, likeNumber=69, createdTime=2019-08-19, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21bc15906861, moduleTitle=INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=21bc15906861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842800, encodeId=0327184280086, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=Blood：去甲基化治疗失败后，MDS应如何治疗？, objectType=article, longId=157275, objectId=476b15e27530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=476b15e27530, replyNumber=0, likeNumber=0, createdTime=2019-08-30, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=476b15e27530, moduleTitle=Blood：去甲基化治疗失败后，MDS应如何治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=476b15e27530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1842805, encodeId=ec1c184280598, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a>, objectTitle=2019 INASL/ISPGHAN/MDSI临床实践指南：Wilson''s病（肝豆状核变性）, objectType=article, longId=166742, objectId=d9c5166e422c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9c5166e422c, replyNumber=0, likeNumber=39, createdTime=2020-03-25, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9c5166e422c, moduleTitle=2019 INASL/ISPGHAN/MDSI临床实践指南：Wilson''s病（肝豆状核变性）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d9c5166e422c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MDS

2020-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#MDS#

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML

2021-10-19

d830372 (审核中...)

前往app查看评论内容

#MDS#

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS

2021-02-03

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：短端粒长度可预测MDS患者干细胞移植后的无复发死亡率

2021-02-10

d830372 (审核中...)

前往app查看评论内容

#MDS#

CAR-T细胞疗法MB-102治疗BPDCN、AML、hrMDS：即将开展多中心I/II期临床试验

2021-09-04

d830372 (审核中...)

前往app查看评论内容

#MDS#

地西他滨联合半相合淋巴细胞输注治疗MDS异基因造血干细胞移植后进展为AML并多次复发1例

2020-10-16

仁心济世 (审核中...)

前往app查看评论内容

#MDS#

阿扎胞苷为MDS去甲基化治疗**

2020-03-17

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：口服cedazuridine/地西他滨治疗MDS和CMML的药代动力学、疗效和安全性

2020-12-05

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：MDS/MPN不同亚型的遗传异质性

2020-10-03

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：SETD2缺陷预示MDS预后不良，并加速MDS-白血病转化

2020-06-11

d830372 (审核中...)

前往app查看评论内容

#MDS#

Lancet Haemat：Shwachman-Diamond综合征合并MDS或AML患者的临床特征及预后

2020-10-26

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：MDS/AML成人患者的生殖细胞DDX41突变

2020-01-11

d830372 (审核中...)

前往app查看评论内容

#MDS#

IJLH：应重新评估将难治性贫血作为MDS/MPN‐RS‐T诊断标准的要求？

2020-02-03

d830372 (审核中...)

前往app查看评论内容

#MDS#

IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS

2020-02-24

d830372 (审核中...)

前往app查看评论内容

#MDS#

Cell Death Dis：间充质干细胞通过扩增MDSCs促进癌细胞存活转移

2020-09-27

d830372 (审核中...)

前往app查看评论内容

#MDS#

高危MDS的治疗策略选择及阿扎胞苷的应用地位及进展

2020-07-04

d830372 (审核中...)

前往app查看评论内容

#MDS#

Prostate：STAT3抑制剂肉盘菌内酯能够抑制类MDSC单核细胞的产生

2019-12-12

d830372 (审核中...)

前往app查看评论内容

#MDS#

Lancet haemat：纳武单抗联合伊达比星和阿糖胞苷可提高AML或高风险MDS患者预后

2020-05-20

d830372 (审核中...)

前往app查看评论内容

#MDS#

INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究

2019-08-19

d830372 (审核中...)

前往app查看评论内容

#MDS#

Blood：去甲基化治疗失败后，MDS应如何治疗？

2019-08-30

d830372 (审核中...)

前往app查看评论内容

#MDS#

2019 INASL/ISPGHAN/MDSI临床实践指南：Wilson''s病（肝豆状核变性）

2020-03-25

科室
- - 订阅+
  - 更多科室
工具
服务